Phase 3 Trial of Concizumab in Hemophilia with Inhibitors

Original Article

T. Matsushita, A. Shapiro, A. Abraham, P. Angchaisuksiri, G. Castaman, K. Cepo, R. d’Oiron, M. Frei-Jones, A.-S. Goh, J. Haaning, S.H. Jacobsen, J. Mahlangu, M. Mathias, K. Nogami, J.S. Rasmussen, O. Stasyshyn, H. Tran, K. Vilchevska, L.V. Martinez, J. Windyga, C.W. You, N. Zozulya, B. Zulfikar, and V. Jiménez-Yuste

N Engl J Med 2023;389:783-794

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
08/30/2023
Course expires: 
08/31/2025

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation